Literature DB >> 1395753

The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura.

H D Beauchamp1, N K Kundra, R Aranson, F Chong, K F MacDonnell.   

Abstract

Malignant mesothelioma of the pleura is a disease that requires a biopsy procedure for a definitive diagnosis. In the past, closed pleural needle biopsy (CPNB) has given poor yields due to the small amount of tissue obtained, and the patient has subsequently been subjected to a diagnostic thoracotomy. In recent years, the availability of more accurate histopathologic tests have enabled the pathologist to make a diagnosis more easily on samples obtained at CPNB. In this retrospective study of 20 consecutive cases of malignant mesothelioma of the pleura diagnosed between 1980 and 1990, we found that a blind CPNB was diagnostic in five of seven procedures and CT-guided CPNB was diagnostic in five of six procedures. An open pleural biopsy (OPB) was diagnostic in ten of ten procedures performed. There were no complications associated with any of the CPNB procedures. We conclude that CPNB is a safe and effective manner of diagnosing malignant mesothelioma of the pleura, and should be attempted prior to OPB.

Entities:  

Mesh:

Year:  1992        PMID: 1395753     DOI: 10.1378/chest.102.4.1110

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

2.  Approach to undiagnosed exudative pleural effusion: the diagnostic yield of blind pleural biopsy.

Authors:  Mehrdad Solooki; Mirmohamad Miri
Journal:  Caspian J Intern Med       Date:  2013

3.  Role of blind closed pleural biopsy in the managment of pleural exudates.

Authors:  Marco F Pereyra; Esther San-José; Lucía Ferreiro; Antonio Golpe; José Antúnez; Francisco-Javier González-Barcala; Ihab Abdulkader; José M Álvarez-Dobaño; Nuria Rodríguez-Núñez; Luis Valdés
Journal:  Can Respir J       Date:  2013-08-15       Impact factor: 2.409

4.  Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.

Authors:  Lucian R Chirieac; Yin P Hung; Wai Chin Foo; Matthias D Hofer; Paul A VanderLaan; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Cancer       Date:  2019-08-07       Impact factor: 6.860

Review 5.  Modern management of malignant pleural mesothelioma.

Authors:  Shivani C Patel; Jonathan E Dowell
Journal:  Lung Cancer (Auckl)       Date:  2016-05-03

6.  Thoracic computed tomography findings in malignant mesothelioma.

Authors:  Omer Tamer Dogan; Ismail Salk; Fikret Tas; Kursat Epozturk; Cesur Gumus; Ibrahim Akkurt; Sefa Levent Ozsahin
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.